Moleculin Biotech, Inc. Common Stock (NASDAQ: MBRX) last traded at $0.442, up 4.25% on the session. The quote above updates while this page is open; the figures below are drawn from Moleculin Biotech, Inc. Common Stock’s own filings and are restated only when a new one is published.
Moleculin Biotech, Inc. Common Stock trades on NASDAQ under the ticker MBRX. Its market capitalisation is $8.61 million.
Valuation measures for Moleculin Biotech, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $8.61M |
|---|---|
| Enterprise value | $10.85M |
| Price / book | 0.74 |
| Beta | 0.60 |
Trailing-twelve-month figures tagged in Moleculin Biotech, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$30.33M |
|---|
| Return on equity | -261.73% |
|---|
| Cash | $7.26M |
|---|
Range and volume for MBRX over the past 52 weeks.
| 52-week high | $15.75 |
|---|---|
| 52-week low | $0.161 |
| Volume | 342.5K |
| Average volume | 1.27M |
| Previous close | $0.424 |
Invest a chosen dollar amount in Moleculin Biotech, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell MBRX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.